Atlas Trials

Phase I Study of INO-1800 With or Without INO-9112 + EP in Chronic Hepatitis B Subjects

Clinical trial NCT02431312 · COMPLETED

Trial details

NCT number
NCT02431312
Sponsor
Inovio Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatitis B
Start date
2015-01-12
Primary completion
2018-05-22
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.